• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Karyopharm Therapeutics Inc

+ Add to Watchlist


42.1000 USD 0.3200 0.75%

As of 17:20:00 ET on 11/25/2014.

Snapshot for Karyopharm Therapeutics Inc (KPTI)

Open: 42.5500 Day's Range: 41.8900 - 44.1600 Volume: 454,218
Previous Close: 42.4200 52wk Range: 15.8200 - 47.9800 1-Yr Rtn: +163.13%

Stock Chart for KPTI

No chart data available.
  • KPTI:US 42.1000
  • 1D
  • 1M
  • 1Y
Interactive KPTI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KPTI

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.1349
Est. EPS (USD) (12/2014) -2.2170
Est. PEG Ratio -
Market Cap (M USD) 1,376.69
Shares Outstanding (M) 32.70
30 Day Average Volume 257,201
Price/Book (mrq) 6.0274
Price/Sale (ttm) 4,318.8773
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KPTI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for KPTI

Karyopharm Therapeutics, Inc. provides biopharmaceutical products and services. The Company develops and discovers drugs for the treatment of cancer, inflammation, and diseases related to cell proliferation through activity modulation of critical pathways. Karyopham Therapeutics serves the healthcare industry throughout the United States.

Michael G KauffmanCEO/Co-FounderSharon ShachamPresident/Chief Scientific Ofcr
Justin A RenzExec VP/CFOChristopher B PrimianoVP/Secretary/General Counsel
More Company Profile & Key Executives for KPTI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil